Cypress Funds Has Lowered By $1.74 Million Its Lockheed Martin (LMT) Stake; Quidel Has 2.41 Sentiment

September 3, 2017 - By Kurt Siggers

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The company has market cap of $1.19 billion. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. It currently has negative earnings. The Firm sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

Cypress Funds Llc decreased Lockheed Martin Corp (LMT) stake by 7.78% reported in 2016Q4 SEC filing. Cypress Funds Llc sold 7,000 shares as Lockheed Martin Corp (LMT)’s stock rose 2.80%. The Cypress Funds Llc holds 83,000 shares with $20.75M value, down from 90,000 last quarter. Lockheed Martin Corp now has $87.03B valuation. The stock decreased 1.05% or $3.2 on September 1, reaching $302.19. About shares traded. Lockheed Martin Corporation (NYSE:LMT) has risen 14.19% since September 3, 2016 and is uptrending. It has underperformed by 2.51% the S&P500.

The stock increased 2.18% or $0.76 on September 1, reaching $35.7. About 283,309 shares traded. Quidel Corporation (QDEL) has risen 56.78% since September 3, 2016 and is uptrending. It has outperformed by 40.08% the S&P500.

Ratings analysis reveals 0 of Quidel’s analysts are positive. Out of 2 Wall Street analysts rating Quidel, 0 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. QDEL was included in 2 notes of analysts from December 16, 2016. The stock of Quidel Corporation (NASDAQ:QDEL) has “Neutral” rating given on Friday, December 16 by Piper Jaffray. The rating was initiated by CL King on Friday, February 17 with “Neutral”.

Since January 1, 0001, it had 0 buys, and 3 selling transactions for $2.78 million activity.

Oracle Investment Management Inc holds 8.94% of its portfolio in Quidel Corporation for 2.52 million shares. Investment Management Of Virginia Llc owns 396,488 shares or 2.03% of their US portfolio. Moreover, Brown Capital Management Llc has 1.79% invested in the company for 5.74 million shares. The California-based Wall Street Associates has invested 1.73% in the stock. Eagle Boston Investment Management Inc, a Massachusetts-based fund reported 328,533 shares.

Cypress Funds Llc increased Alexion Pharmaceuticals Inc (NASDAQ:ALXN) stake by 115,000 shares to 193,000 valued at $23.61M in 2016Q4. It also upped Tri Pointe Group Inc (NYSE:TPH) stake by 285,000 shares and now owns 1.53M shares. Spectrum Brands Hldgs Inc (NYSE:SPB) was raised too.